Abstract:There has been a dramatic increase in the application of new technologies for the treatment of cancerous tumors over the past decade, but for the most part, the treatment of most tumors still involves some combination of invasive surgery, chemotherapy and radiation treatments. Photodynamic therapy (PDT), which involves the activation of an administered compound with laser light followed by a series of events leading to programmed cell death of the tumor, has been proposed as a noninvasive alternative treatment to replace the standard surgery/chemotherapy/radiation protocol. However, currently approved PDT agents operate in the Visible portion of the spectrum, and laser light in this region cannot penetrate the skin more than a few millimeters. Two-photon irradiation using more highly penetrating Near-infrared (NIR) light in the tissue transparency window (700-1000 nm) has been proposed for the treatment of subcutaneous tumors, but most porphyrins exhibit extremely small two-photon cross-sections. Classical PDT also suffers from the lengthy time necessary for accumulation at the tumor site, a relative lack of discrimination between healthy and diseased tissue, particularly at the tumor margins, and difficulty in clearing from the system in a reasonable amount of time. We have recently discovered a new design paradigm for porphyrins with greatly enhanced two-photon cross-sections, and are now proposing a nano-ensemble that would also incorporate small molecule targeting agents, and possibly one-photon NIR imaging agents along with these porphyrins in one therapeutic agent. Thus these ensembles would incorporate targeting/imaging/PDT functions in one therapeutic agent, and hold the promise of single-session outpatient treatment of a large variety of subcutaneous tumors.

In vivo wireless photonic photodynamic therapy

Fully implantable and battery-free wireless optoelectronic system for modulable cancer therapy and real-time monitoring

Advanced techniques for performing photodynamic therapy in deep-seated tissues

A self-powered wireless detachable drug/light injector for metronomic photodynamic therapy in cancer treatment

Photodynamic Therapy: A Flexi‐PEGDA Upconversion Implant for Wireless Brain Photodynamic Therapy (adv. Mater. 29/2020)

Fully Implantable and Retrievable Upconversion Waveguides for Photodynamic Therapy in Deep Tissue (Advanced Optical Materials 19/2023)

Implantable self-powered therapeutic pellet for wireless photodynamic/sonodynamic hybrid therapy of cancer recurrence inhibition and tumor regression

In Vivo Targeted Deep-Tissue Photodynamic Therapy Based on Near-Infrared Light Triggered Upconversion Nanoconstruct

Photodynamic Therapy for Deep Organ Cancer by Implantable Wireless OLEDs

Programming DNA Nanoassembly for Enhanced Photodynamic Therapy

In vivo photodynamic therapy using upconversion nanoparticles as remote-controlled nanotransducers

Injectable Optical System for Drug Delivery, Ablation, and Sampling in Deep Tissue

Near-infrared Rechargeable “optical Battery” Implant for Irradiation-Free Photodynamic Therapy

Wireless sequential dual light delivery for programmed PDT in vivo

Nanoscintillator-mediated X-ray Inducible Photodynamic Therapy for in Vivo Cancer Treatment.

Nanophotonic Ensembles for Targeted Multi-Photon Photodynamic Therapy

SIRIUS, Ultra-Scintillating Upconversion Breast Implant for Remote Orthotopic Photodynamic Therapy

Exploration of New Sensitizers for Photodynamic Therapy Targeting Deep Cancer Treatment

X-ray Activated Nanoplatforms for Deep Tissue Photodynamic Therapy

Near-infrared-II Triggered Inorganic Photodynamic Nanomedicines for Deep-Tissue Therapy

Stem-Cell-Membrane Camouflaging on Near-Infrared Photoactivated Upconversion Nanoarchitectures for in Vivo Remote-Controlled Photodynamic Therapy